Is Vigabatrin included in medical insurance?
Vigabatrin is an oral powder mainly used to treat refractory epilepsy, especially infantile spasms (West syndrome). The drug's mechanism of action is to inhibit γ-aminobutyric acid (GABA) aminotransferase and increase the GABA concentration in the brain, thereby effectively reducing nerve excitation and controlling epileptic seizures. This mechanism allows Vigabatrin to show better effects in many cases where traditional anti-epileptic drugs are ineffective, and is especially suitable for the treatment of infants and other refractory epilepsy types.
The dose of Vigabatrin is usually adjusted based on the patient's age, weight and specific condition. As an oral powder, its dosage adjustment is relatively flexible and is more suitable for infants and young children. When treating infantile spasms, doctors generally start with a lower dose and gradually increase it to the ideal therapeutic level to ensure efficacy and minimize side effects. Long-term use of Vigabatrin may cause adverse reactions such as visual field loss, so patients need to undergo regular vision examinations during treatment to ensure safety.

Regarding medical insurance information, Vigabatrin has been launched in the Chinese market and has been included in medical insurance. This means that eligible patients can enjoy medical insurance reimbursement when purchasing Vigabatrin, reducing their financial burden. Specific medical insurance policies and reimbursement ratios may vary by region. Patients are advised to consult the local hospital pharmacy or medical insurance center for detailed information.
The market price of Vigabatrin is also relatively reasonable. The current price of 500mg 30 bags is around more than 1,000 yuan. It is worth mentioning that the original drug in Hong Kong, China, is also 500mg per 100 bags, and the price is more than one thousand yuan, while some foreign generic drugs provide more economical options. The price of 500mg of the same specifications is around a few hundred yuan, and the ingredients of the drugs are basically the same.
In summary, Vigabatrin, as an effective anti-epileptic drug, has been included in medical insurance, providing patients with an important treatment option. Patients should follow their doctor's instructions during use to ensure the best therapeutic effect and safety.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)